GeneDx appoints Mark Gardner as President to lead commercial and operations
GeneDx Holdings Corp. named Mark Gardner, former Senior Vice President at Quest Diagnostics, as President effective June 15, 2026, reporting to CEO Katherine Stueland. The appointment aims to strengthen commercial execution and operational scaling in the rare disease genomics diagnostics market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day